HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target

Histopathology. 2010 Nov;57(5):763-4. doi: 10.1111/j.1365-2559.2010.03689.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenocarcinoma, Mucinous / genetics*
  • Adenocarcinoma, Mucinous / therapy
  • Female
  • Gene Amplification*
  • Humans
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / therapy
  • Receptor, ErbB-2 / antagonists & inhibitors
  • Receptor, ErbB-2 / genetics*
  • Receptor, ErbB-2 / metabolism

Substances

  • ERBB2 protein, human
  • Receptor, ErbB-2